ATE83651T1 - Acetylcystein enthaltende mundloesliche arzneimittel. - Google Patents

Acetylcystein enthaltende mundloesliche arzneimittel.

Info

Publication number
ATE83651T1
ATE83651T1 AT89107231T AT89107231T ATE83651T1 AT E83651 T1 ATE83651 T1 AT E83651T1 AT 89107231 T AT89107231 T AT 89107231T AT 89107231 T AT89107231 T AT 89107231T AT E83651 T1 ATE83651 T1 AT E83651T1
Authority
AT
Austria
Prior art keywords
pharmaceuticals containing
oral pharmaceuticals
acetylcysteine
containing acetylcysteine
oral
Prior art date
Application number
AT89107231T
Other languages
English (en)
Inventor
Antonio Ziggiotti
Paolo Lualdi
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Application granted granted Critical
Publication of ATE83651T1 publication Critical patent/ATE83651T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89107231T 1988-04-29 1989-04-21 Acetylcystein enthaltende mundloesliche arzneimittel. ATE83651T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20386/88A IT1217445B (it) 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina
EP89107231A EP0339508B1 (de) 1988-04-29 1989-04-21 Acetylcystein enthaltende mundlösliche Arzneimittel

Publications (1)

Publication Number Publication Date
ATE83651T1 true ATE83651T1 (de) 1993-01-15

Family

ID=11166252

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89107231T ATE83651T1 (de) 1988-04-29 1989-04-21 Acetylcystein enthaltende mundloesliche arzneimittel.

Country Status (6)

Country Link
US (1) US4970236A (de)
EP (1) EP0339508B1 (de)
AT (1) ATE83651T1 (de)
DE (1) DE68903988T2 (de)
ES (1) ES2052802T3 (de)
IT (1) IT1217445B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
DK0481294T4 (da) * 1990-10-19 2001-06-18 Spirig Ag Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
WO1995017900A1 (en) * 1993-12-30 1995-07-06 Arcturus Pharmaceutical Corporation Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
US5962421A (en) * 1996-05-16 1999-10-05 Zambon, S.A. Pharmacological association between N-acetylcysteine and levulose for preventing cellular death and related diseases
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
DE839528T1 (de) * 1996-10-29 1998-10-22 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
WO1998021983A1 (en) * 1996-11-20 1998-05-28 Sang Whang Enterprises, Inc. Potassium and sodium bicarbonate for increased blood buffers
AU5142699A (en) 1998-07-31 2000-02-28 Mount Sinai Hospital Corporation Methods and compositions for increasing insulin sensitivity
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
US10139321B2 (en) * 2016-07-29 2018-11-27 Alpha-Tec Systems, Inc. Mucolytic tablet for a sample collection device
FI3678739T3 (fi) 2017-09-07 2024-05-21 Childrens Hospital Philadelphia Koostumuksia ja menetelmiä periytyvän kystatiini c -amyloidiangiopatian (hccaa) ja muiden poikkeaviin amyloidikertymiin liittyvien hermostoa rappeuttavien häiriöiden hoitoon

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE304574C (de) *
US2888380A (en) * 1954-11-05 1959-05-26 Merck & Co Inc S-ethyl cysteine compositions for combatting tubercle bacilli
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1451177A (fr) * 1962-03-06 1966-01-07 Degussa Procédé de préparation d'une n-acylhomocystéine thiolactone
US3591686A (en) * 1967-08-01 1971-07-06 Mead Johnson & Co Anti-inflammatory compositions and methods utilizing n-acylcysteines and the beta-alkyl and carboxyl derivatives thereof
US3629452A (en) * 1968-02-19 1971-12-21 Oreal Method of reducing excessive secretions of sebum by oral administration of amino acid derivatives
USRE29256E (en) * 1969-10-07 1977-06-07 Recherche Pharmaceutiques Et Scientifiques Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
IT1194474B (it) * 1983-11-23 1988-09-22 Magis Farmaceutici Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
CH666814A5 (it) * 1986-07-24 1988-08-31 Inpharzam Int Sa Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .

Also Published As

Publication number Publication date
IT1217445B (it) 1990-03-22
IT8820386A0 (it) 1988-04-29
DE68903988D1 (de) 1993-02-04
EP0339508B1 (de) 1992-12-23
US4970236A (en) 1990-11-13
EP0339508A1 (de) 1989-11-02
DE68903988T2 (de) 1993-06-17
ES2052802T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
ATE83651T1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
MX9203480A (es) Formulaciones medicinales en aereosol.
IL90550A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE121089T1 (de) Optisch aktives 5h-pyrrolo(3,4-b>pyrazinderivat, seine herstellung und pharmazeutische zubereitungen die es enthalten.
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
DE3854148D1 (de) Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten.
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
FI892762A0 (fi) Foerfarande foer framstaellning av estrogenprodukt.
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
DE69534283D1 (de) Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
DE3685604D1 (de) 1,7-naphthyridinderivate und diese enthaltende arzneimittel.
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
NO944531L (no) Diaminsalter av clavulansyre
DE3782112D1 (de) Pyrimidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
ATA36788A (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE68900152D1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
GB2021409A (en) Pharmaceutical composition
DE68905171D1 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
FI863470A (fi) 6-fenoximetyl-4 -hydroxitetrahydropyran-2-oner, foerfarande foer deras framstaellning, deras anvaendning som laekemedel farmaceutiska produkter och mellanprodukter.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties